A devastating aspect of
cancer cachexia is severe loss of muscle and fat mass. Though
cachexia occurs in both sexes, it is not well-defined in the female. The Apc(Min/+) mouse is genetically predisposed to develop intestinal
tumors; circulating
IL-6 is a critical regulator of
cancer cachexia in the male Apc(Min/+) mouse. The purpose of this study was to examine the relationship between
IL-6 signaling and
cachexia progression in the female Apc(Min/+) mouse. Male and female Apc(Min/+) mice were examined during the initiation and progression of
cachexia. Another group of females had
IL-6 overexpressed between 12 and 14 weeks or 15-18 weeks of age to determine whether
IL-6 could induce
cachexia. Cachectic female Apc(Min/+) mice lost
body weight, muscle mass, and fat mass; increased muscle
IL-6 mRNA expression was associated with these changes, but circulating
IL-6 levels were not. Circulating
IL-6 levels did not correlate with downstream signaling in muscle in the female. Muscle IL-6r
mRNA expression and SOCS3
mRNA expression as well as muscle IL-6r
protein and STAT3 phosphorylation increased with severe
cachexia in both sexes. Muscle
SOCS3 protein increased in cachectic females but decreased in cachectic males.
IL-6 overexpression did not affect
cachexia progression in female Apc(Min/+) mice. Our results indicate that female Apc(Min/+) mice undergo
cachexia progression that is at least initially IL-6-independent. Future studies in the female will need to determine mechanisms underlying regulation of
IL-6 response and
cachexia induction.